- Feature Project
-
- Sleep apnea and cardiovascular disease
- A China-Australia collaborative, multi-centre program of research to establish the benefits of treatment of obstructive sleep apnea (OSA) on cardiovascular outcomes. OSA is a very common condition characterised by varying degrees of repetitive episodes of upper airway obstruction (apnea) or narrowing (hypopnea) during sleep, loud snoring, and daytime sleepiness. 10% of middle-aged men and 4% of middle-aged women have significant OSA (ie >15 obstructive events per hour of sleep).
- Key programs
-
-
Investigating treatments for kidney failure
Investigating treatments for kidney failure
-
-
Improving chances of recovery for stroke patients
A major program studying the effects of lowering blood pressure following stroke - INTERACT.
-
-
Improving treatment of critically ill patients
The largest trial of ICU patients has shown intense glucose lowering increases the risk of death.
-
-
The largest study of type 2 diabetes treatments
ADVANCE study results continue to improve treatment of type 2 diabetes patients.
“I commend Dr Stephen MacMahon, the chief investigator of the Action in Diabetes and Vascular Disease (ADVANCE) study, who led the team from 20 countries worldwide in the study which involved 11,140 patients with Type 2 diabetes who were treated and followed up over five years.”
Minister for Health and Ageing, The Hon. Nicola Roxon
